Covid-19 vaccines: authorised

4. August 2022 – The European Medicines Agency (EMA) published updated product information for Covid-19 vaccine Valneva following an increase in its approved shelf life. Covid-19 vaccine Valneva is a vaccine for protecting people aged between 18 and 50 years against Covid-19. It is used for primary vaccination.

For more information, see here.